Jones, M L
RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation. [electronic resource]
- Journal of thrombosis and haemostasis : JTH Mar 2010
- 567-76 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1538-7836
Standard No.: 10.1111/j.1538-7836.2009.03719.x doi
Subjects--Topical Terms: Benzodiazepines--pharmacology Biomimetics Blood Coagulation--drug effects Blood Platelets--drug effects Calcium Signaling--drug effects Enzyme Activation Humans Immunoglobulin gamma-Chains--blood Intracellular Signaling Peptides and Proteins--blood Ligands Oligopeptides--blood Phosphatidylserines--blood Phosphorylation Piperidines--pharmacology Platelet Activation--drug effects Platelet Aggregation Inhibitors--adverse effects Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors Platelet Membrane Glycoproteins--metabolism Protein Conformation Protein-Tyrosine Kinases--blood Purinergic P2 Receptor Antagonists Receptors, Purinergic P2--blood Receptors, Purinergic P2Y12 Secretory Vesicles--drug effects Syk Kinase Time Factors Tirofiban Tyrosine--analogs & derivatives src-Family Kinases--blood